NCT05512546CompletedNot Applicable
Coil Embolization and Thromboembolic Complications in Patients With Ruptured Aneurysms
Muhammad Hassan1 site in 1 country200 target enrollmentStarted: February 10, 2017Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- High Intensity Areas
Study Overview
Brief Summary
Clopidogrel has been to be reported to be superior to aspirin for the prevention of thromboembolic complications associated with coil embolization in patients with ruptured aneurysms.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 45 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •All the patients enrolled in the study underwent MRI and Angiography.
- •Participants included in the study were confirmed on assessment, and verified for ruptured aneurysm by imaging using either computed tomography (CT) or MRI.
Exclusion Criteria
- •Patients with any history of sensitivity or reaction to aspirin, or any contraindication for MRI, were excluded from the study.
Arms & Interventions
Aspirin Group
patients were prescribed 75 mg/day of either aspirin for 6 months
Intervention: Aspir-Low Pill (Drug)
Clopidogrel Group
75mg/day prescribed for 6 months
Intervention: Aspir-Low Pill (Drug)
Outcomes
Primary Outcomes
High Intensity Areas
Time Frame: 3 months
Post Procedural
Secondary Outcomes
- High Intensity Areas(at 6 months)
Investigators
Muhammad Hassan
Registrar Neurology
Shaheed Zulfiqar Ali Bhutto Medical University
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Phase 3
ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft SurgeryGraft PatencyCoronary Artery Bypass Grafting SurgeryHypercoagulabilityThrombosisNCT01046942Rigshospitalet, Denmark250
Completed
Not Applicable
Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and TransfusionCoronary Artery DiseaseNCT01060163Chinese Academy of Medical Sciences, Fuwai Hospital552
Active, not recruiting
Not Applicable
Aspirin and clopidogrel versus aspirin alone for the prevention of blood clots following transcatheter aortic valve Implantation.EUCTR2014-001675-32-ESIUCPQ300
Withdrawn
Phase 2
Clopidogrel and Aspirin for the Treatment of Polycythemia VeraPolycythemia VeraNCT00940784Ronald Hoffman
Completed
Not Applicable
VerifyNow French RegistryStent ThrombosisClopidogrelAspirinBleedingAngioplastyNCT00753753Association Pour le Développement des Soins Cardiologiques de la ville de Chartres1,001